Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-03-15Clinical Trial Update: Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery [Phase 4]
A Phase 4 clinical trial evaluating safety and efficacy of correcting hyperglycemia in patients with Type 1 or Type 2 diabetes undergoing ou…
-
CLINICAL_TRIALS withdrawal · 2017-03-15Clinical Trial Update: Clinical Islet Transplantation Using the Edmonton Protocol
A clinical trial evaluating islet transplantation for type 1 diabetes using the Edmonton protocol has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Insulin Clamp Ancillary Study for Assessment of Insulin Resistance [Phase 3]
A completed Phase 3 clinical trial update on an insulin clamp ancillary study to assess insulin resistance in individuals with Type 1 diabet…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes [Phase 1]
This clinical trial update reports the pharmacokinetic assessment of FIAsp (fast-acting insulin aspart) in children, adolescents, and adults…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003) [Phase 3]
Phase 3 trial comparing MK-1293 to Lantus in type 1 diabetes completed with results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005) [Phase 1]
Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of MK-1293 compared with basal insulin in adu…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes [Phase 3]
Phase 3 trial evaluating liraglutide as an adjunct to insulin in Type 1 diabetes mellitus, reporting on efficacy and safety. Results were po…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes [Phase 2, Phase 3]
A study evaluating intranasal glucagon for children and adolescents with Type 1 diabetes has completed Phase 2/3 trials with posted results.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting [Phase 2]
Phase 2 clinical trial in children and adolescents with Type 1 diabetes mellitus completed, evaluating home-based 'closing the loop' managem…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Automated Closed-loop in Children and Adolescents With Type 1 Diabetes [NA]
A completed clinical trial update on automated closed-loop insulin delivery in children and adolescents with Type 1 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion [NA]
The clinical trial update reports that a pilot study evaluating the Vigilant Diabetes Management Companion for nocturnal hypoglycemia preven…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: T1 Diabetes Hypoglycemia Prevention Pilot [NA]
A pilot clinical trial on preventing hypoglycemia in individuals with Type 1 diabetes has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Closing the Loop 24/7 in Adolescents With Type 1 Diabetes [NA]
Clinical trial update noting completion of the study 'Closing the Loop 24/7 in Adolescents With Type 1 Diabetes' sponsored by the University…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes [Phase 2]
A Phase 2 trial comparing human insulin to an insulin inhalation solution in children with type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating inhaled human insulin in people with diabetes mellitus and chronic obstructive pulmonary disease has been terminate…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes [Phase 3]
A Phase 3 long-term safety trial compares preprandial inhaled human insulin with subcutaneous insulin aspart, both given with NPH, in subjec…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes [Phase 3]
A Phase 3 trial comparing insulin aspart produced by the NN2000 manufacturing process with the current process in Type 1 diabetes mellitus; …
-
CLINICAL_TRIALS research · 2017-02-28Clinical Trial Update: A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes
A qualitative study update examining the use of continuous subcutaneous insulin infusion (CSII) in children and adolescents with Type 1 diab…
-
CLINICAL_TRIALS research · 2017-02-28Clinical Trial Update: Observational Study With InnoLet® in Daily Clinical Practice
Observational study evaluating the InnoLet insulin pen in daily clinical practice. The study has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction
This is an observational trial update assessing patient satisfaction with Mixtard 30 NovoLet insulin in individuals with diabetes, with the …
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles [Phase 3]
Phase 3 trial sponsored by Novo Nordisk evaluated localization of potential insulin deposits using 6 mm and 12 mm long needles in adults wit…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
This document reports the completion of a NovoLet surveillance trial in Indonesia evaluating the use of NovoLet (insulin human) for diabetes…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes [Phase 3]
Phase 3 trial comparing insulin produced by the current manufacturing process with the NN729 production process in Type 1 diabetes mellitus.…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes Mellitus [NA]
A completed clinical trial evaluated the use of a real-time continuous glucose monitoring system in patients with Type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Early Dietary Intervention and Later Signs of Beta-Cell Autoimmunity [NA]
Clinical trial update on an early dietary intervention and later signs of beta-cell autoimmunity in Type 1 diabetes.